TAS2R43: A Potential Drug Target for Neurological Disorders (G259289)

Target Name: TAS2R43

NCBI ID: G259289

TAS2R43

TAS2R43: A Potential Drug Target for Neurological Disorders

TAS2R43 (T2R52) is a protein that is expressed in the brain and is known for its role in the regulation of dopamine release. It is a potential drug target for the treatment of various neurological disorders, including Parkinson's disease, addiction, and schizophrenia.

TAS2R43 is a transmembrane protein that is expressed in the brain and is involved in the regulation of dopamine release. It is a key protein in the dopamine transporter, which is responsible for transporting dopamine from the brain's surface to the dopamine-containing neurons.

Research has shown that TAS2R43 plays a crucial role in the regulation of dopamine release and that it is involved in the development and progression of various neurological disorders. For example, studies have shown that TAS2R43 is involved in the treatment of Parkinson's disease, addiction, and schizophrenia.

One of the key features of TAS2R43 is its role in the regulation of dopamine release. Dopamine is a neurotransmitter that is involved in the regulation of various brain functions, including movement, emotion, and motivation. TAS2R43 is involved in the regulation of dopamine release by interacting with the dopamine transporter.

TAS2R43 is also involved in the regulation of neurotransmitter release and in the development of addictions. Studies have shown that TAS2R43 is involved in the regulation of the release of drugs of abuse, such as opiates and alcohol, and that its expression is associated with the development of addiction.

In addition to its role in the regulation of neurotransmitter release, TAS2R43 is also involved in the regulation of inflammation. Studies have shown that TAS2R43 is involved in the regulation of the production of pro-inflammatory cytokines and that its expression is associated with the development of inflammatory diseases, including schizophrenia.

TAS2R43 is also involved in the regulation of cell survival. Studies have shown that TAS2R43 is involved in the regulation of cell survival and that its expression is associated with the development of neurodegenerative diseases, including Parkinson's disease.

TAS2R43 is a potential drug target for the treatment of various neurological disorders. Studies have shown that TAS2R43 is involved in the regulation of dopamine release and that its inhibition can lead to the improvement of symptoms in patients with Parkinson's disease, addiction, and schizophrenia. In addition, TAS2R43 is also involved in the regulation of neurotransmitter release and in the development of addictions, making it a potential target for the treatment of substance abuse. Furthermore, TAS2R43 is also involved in the regulation of cell survival and that its inhibition may lead to the improvement of symptoms in neurodegenerative diseases.

In conclusion, TAS2R43 is a protein that is expressed in the brain and is involved in the regulation of dopamine release. It is a key protein in the dopamine transporter and its regulation of dopamine release plays a crucial role in the development and progression of various neurological disorders. TAS2R43 is also involved in the regulation of neurotransmitter release and in the development of addictions, making it a potential drug target for the treatment of these disorders. Furthermore, TAS2R43 is also involved in the regulation of cell survival and that its inhibition may lead to the improvement of symptoms in neurodegenerative diseases. Further research is needed to fully understand the role of TAS2R43 in the regulation of dopamine release and its potential as a drug target.

Protein Name: Taste 2 Receptor Member 43

Functions: Gustducin-coupled receptor immplicated in the perception of bitter compounds in the oral cavity and the gastrointestinal tract. Signals through PLCB2 and the calcium-regulated cation channel TRPM5. Activated by the sulfonyl amide sweeteners saccharin and acesulfame K. In airway epithelial cells, binding of bitter compounds increases the intracellular calcium ion concentration and stimulates ciliary beat frequency. May act as chemosensory receptors in airway epithelial cells to detect and eliminate potential noxious agents from the airways (By similarity)

The "TAS2R43 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TAS2R43 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets